Creatine is best known for supporting rapid energy regeneration in muscle. Recent human research is examining whether the same phosphocreatine system may also help the brain manage periods of unusually high energy demand.
Two randomized, double-blind crossover trials tested single doses of creatine monohydrate during approximately 21 hours of sleep deprivation. Both reported that creatine reduced deterioration in selected cognitive tasks. The findings add a credible research direction beyond sports performance, although the doses and conditions were very different from everyday supplementation.
What the 2024 High-Dose Study Measured
The 2024 trial included 15 healthy adults, eight of whom were women. Participants received either creatine monohydrate or placebo on separate experimental nights.
The creatine dose was 0.35 g/kg—approximately 24.5 g for a 70 kg adult. Testing occurred at baseline and about 3, 5.5 and 7.5 hours after supplementation during a sleepless night.
The researchers combined cognitive testing with proton and phosphorus magnetic resonance spectroscopy. Creatine was associated with improvements in several language, logic, numerical, memory and processing-speed outcomes. The imaging results also showed changes in:
● phosphocreatine-to-inorganic-phosphate balance;
● ATP-related signals;
● total cerebral creatine;
● brain pH.
The value of this study lies in the combination of performance and metabolic measurements. It suggests that the cognitive findings occurred alongside measurable changes in cerebral energy metabolism rather than relying only on subjective reports.
What Changed When the Dose Was Reduced
The 2026 follow-up trial expanded the sample to 29 healthy adults and reduced the single dose to 0.2 g/kg. The average amount administered was 14.1 ± 3 g.
Participants completed cognitive tests at baseline and approximately 3, 5.5 and 7.5 hours after taking creatine or placebo. The study again used a randomized, double-blind crossover design, meaning each participant completed both conditions.
When results from the three post-dose time points were pooled, creatine was associated with:
●6.1% improvement in logic performance;
●6.2% improvement in numerical tasks;
●12.3% faster language-processing time;
●9.2% improvement in reaction-time consistency during the Psychomotor Vigilance Test.
The researchers described the effect as modest and less pronounced than with 0.35 g/kg, but still observed improvements of up to approximately 12%.
Unlike the 2024 study, the follow-up did not include brain spectroscopy. It therefore strengthened the cognitive pattern at a lower dose without directly repeating the cerebral-energy measurements.
Earlier Human Studies Pointed in the Same Direction
The idea that creatine may be particularly useful under sleep stress did not begin with these two trials.
A 2006 study followed 19 participants through 24 hours of sleep deprivation after a creatine-loading protocol. Creatine was associated with smaller declines in mood and tasks placing greater demand on the prefrontal cortex.
A related randomized trial used 20 g per day for seven days and extended sleep deprivation to 36 hours with intermittent exercise. The creatine group performed better on a complex central-executive task at 36 hours, although other cognitive, mood and psychomotor measures did not differ.
In 2011, 10 elite rugby players completed repeated passing tests after normal sleep and after sleeping only 3–5 hours. Sleep loss reduced passing accuracy under placebo, while acute creatine doses of 50 or 100 mg/kg prevented the same decline in that specific skill test.
These studies used different doses, populations and outcomes, but together they suggest that creatine’s cognitive effects may become more visible when sleep loss places additional pressure on energy-demanding tasks.
What the Findings Do—and Do Not—Show
The findings are encouraging, but they come mainly from small studies involving young, healthy adults under controlled sleep deprivation.
The latest single doses—approximately 14–25 g for many adults—were considerably higher than the 3–5 g commonly used in daily products. The results therefore do not show that an ordinary daily serving will produce the same immediate cognitive response.
They also do not suggest that creatine replaces sleep. The most accurate interpretation is that high-dose creatine may help preserve selected aspects of performance during acute sleep loss.
What This Means for Creatine Product Development
The research creates opportunities for products designed around high-demand situations, but the studied doses introduce practical challenges.
Delivering 14–25 g in capsules would be difficult. Powder tubs, larger stick packs or divided-dose systems may be more realistic, provided that dispersibility, flavor, gastrointestinal tolerance and complete dose delivery are evaluated in the finished product.
Product communication also needs care. In May 2026, the European Commission declined to authorize the broad claim that daily creatine supplementation improves cognitive function because a general cause-and-effect relationship had not been established across cognitive domains. The sleep-deprivation studies remain scientifically valuable, but they do not create a general authorized cognitive claim in the EU.
Published research explains the opportunity at ingredient level. Reliable product development still depends on the quality of the material entering the formula, including creatine assay, creatinine, DCD, DHT, heavy metals, particle size, dispersibility and batch consistency.
At SRS Nutrition Express, we keep these two questions separate: research indicates where creatine may have new applications, while batch-specific testing establishes whether the supplied creatine meets the requirements of the intended product.
That distinction allows brands to explore cognitive and high-demand applications without making promises that extend beyond the evidence.
References
1. Gordji-Nejad A, Matusch A, Kleedörfer S, et al. Single Dose Creatine Improves Cognitive Performance and Induces Changes in Cerebral High Energy Phosphates During Sleep Deprivation. Scientific Reports. 2024;14:4937. doi: 10.1038/s41598-024-54249-9.
2. Gordji-Nejad A, et al. Single-Dose Creatine Reduces Sleep Deprivation-Induced Deterioration in Cognitive Performance. Nutrients. 2026;18(8):1192. doi: 10.3390/nu18081192.
3. McMorris T, Harris RC, Swain J, et al. Effect of Creatine Supplementation and Sleep Deprivation, with Mild Exercise, on Cognitive and Psychomotor Performance and Mood State. Psychopharmacology. 2006;185:93–103.
4. McMorris T, Harris RC, Howard AN, et al. Creatine Supplementation, Sleep Deprivation, Cortisol, Melatonin and Behavior. Physiology & Behavior. 2007;90:21–28. doi: 10.1016/j.physbeh.2006.08.024.
5. Cook CJ, Crewther BT, Kilduff LP, Drawer S, Gaviglio CM. Skill Execution and Sleep Deprivation: Effects of Acute Caffeine or Creatine Supplementation. JISSN. 2011;8:2. doi: 10.1186/1550-2783-8-2.
6. European Commission. Commission Regulation (EU) 2026/1118 Refusing to Authorise a Health Claim Related to Creatine and Cognitive Function. 2026.
Post time: Jul-27-2026
